Breaking News, Promotions & Moves

AskBio Appoints Gustavo Pesquin as CEO

Sheila Mikhail, Co-Founder and the company's first CEO, will transition to a part-time role as Adviser/Co-Founder.

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Asklepios BioPharmaceutical, Inc. (AskBio), a wholly owned and independently operated subsidiary of Bayer AG, has appointed Gustavo Pesquin as the company’s next Chief Executive Officer. Pesquin joins the company from Amneal Pharmaceuticals, Inc., where he served as Chief Commercial Officer.   Sheila Mikhail, Co-Founder and the company’s first CEO, will transition to a part-time role as Adviser/Co-Founder, and will remain a member of AskBio’s Board.   Under Mikhail’s ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters